Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

COVID-19: Which Drug, When, and Why? Antiviral Agents

COVID-19: Which Drug, When, and Why? Antiviral Agents

FromCCO Infectious Disease Podcast


COVID-19: Which Drug, When, and Why? Antiviral Agents

FromCCO Infectious Disease Podcast

ratings:
Length:
23 minutes
Released:
Apr 25, 2022
Format:
Podcast episode

Description

Antiviral agents continue to be effective against different strains of SARS-CoV-2 when used early in the disease course. In this episode, learn about the role of antiviral agents in hospitalized and high-risk nonhospitalized patients with COVID-19 and in different age groups. Listen as David A. Wohl, MD, discusses when and how to use IV and oral antiviral agents including:Nirmatrelvir + ritonavirRemdesivirMolnupiravirPresenter:David A. Wohl, MDProfessor of MedicineSchool of MedicineSite Leader, Global Infectious Diseases Clinical Trials UnitUniversity of North Carolina at Chapel HillChapel Hill, North CarolinaReview the downloadable slidesets at:https://bit.ly/3Ou4tbELink to full program: https://bit.ly/3EBdf38
Released:
Apr 25, 2022
Format:
Podcast episode

Titles in the series (100)

Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Clinical Care Options. Gain practical strategies and earn CME/CE credit for selected episodes.